SCHEMBL19659161

SCHEMBL19659161

CCNc1cc(C(=O)OC)ncc1C=N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 4/20 0.40
▸ LCK P06239 1/20 0.39
▸ GABRA1 P14867 5/20 0.37
▸ GABRG2 P18507 5/20 0.37
▸ GABRB3 P28472 5/20 0.37
▸ GABRA5 P31644 5/20 0.37
▸ GABRA3 P34903 5/20 0.37
▸ GABRA2 P47869 4/20 0.37
▸ GABRP O00591 3/20 0.37
▸ GABRD O14764 3/20 0.37
▸ GABRB1 P18505 3/20 0.37
▸ GABRB2 P47870 3/20 0.37
▸ GABRA4 P48169 3/20 0.37
▸ GABRE P78334 3/20 0.37
▸ GABRA6 Q16445 3/20 0.37
▸ GABRG1 Q8N1C3 3/20 0.37
▸ GABRG3 Q99928 3/20 0.37
▸ GABRQ Q9UN88 3/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ PDE5A O76074 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18945474 0.79 MAPK1 (0.41) MAPK1LCKGABRA1GABRG2GABRB3
SCHEMBL882196 0.69 HCAR3 (0.46) MAPK1LCKGABRA1GABRG2GABRB3
SCHEMBL68869 0.66 MAPK1 (0.63) MAPK1LCKGABRA1GABRG2GABRB3
SCHEMBL24070459 0.66 MAPK1 (0.42) MAPK1LCKGABRA1GABRG2GABRB3
SCHEMBL30209743 0.66 MAPK1 (0.42) MAPK1LCKGABRA1GABRG2GABRB3
SCHEMBL18825226 0.66 MAPK1 (0.53) MAPK1LCKGABRA1GABRG2GABRB3
SCHEMBL23767845 0.65 MAPK1 (0.45) MAPK1LCKGABRA1GABRG2GABRB3
SCHEMBL23623861 0.65 ALDH1A1 (0.47) MAPK1LCKGABRA1GABRG2GABRB3
SCHEMBL21616761 0.65 MAPK1 (0.45) MAPK1LCKGABRA1GABRG2GABRB3
SCHEMBL18725369 0.65 MAPK1 (0.45) MAPK1LCKGABRA1GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3760625-A1 BICYCLIC LACTAMS AS RECEPTOR-INTERACTING PROTEIN-1 (RIP1) KINASE INHIBITORS FOR TREATING E.G. INFLAMMATORY DISEASES F. Hoffmann-La Roche AG (CH) 2021-01-06 — — EP disclosed
WO-2017004500-A9 BICYCLIC LACTAMS AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2017-11-30 — — WO disclosed
Send feedback